Cardiff Oncology, Inc. (CRDF)
2.925
-0.04
(-1.52%)
USD |
NASDAQ |
Jan 23, 15:46
Cardiff Oncology EPS Diluted (Quarterly): -0.1684 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| AIM ImmunoTech, Inc. | -1.567 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.26M |
| Revenue (Quarterly) | 0.12M |
| Total Expenses (Quarterly) | 11.38M |
| Enterprise Value | 140.48M |
| Gross Profit Margin (Quarterly) | -86.67% |
| Profit Margin (Quarterly) | -9.38K% |
| Earnings Yield | -27.13% |
| Normalized Earnings Yield | -27.13 |